Kailey Walsh

Kailey Walsh is a seasoned professional in clinical research and project management, currently serving as a Manager at Alnylam Pharmaceuticals, where responsibilities include overseeing a global Phase II CNS study and managing the integration of project team activities. Previously, as a Clinical Trial Manager, Kailey managed multiple Phase II and III global studies in various conditions, ensuring adherence to regulatory standards and optimizing operational management. Kailey has also held roles at bluebird bio and Massachusetts General Hospital, contributing to pivotal clinical studies and overseeing research activities. With educational qualifications from the College of Charleston in Biology and Latin Language and Literature, Kailey has demonstrated a strong commitment to advancing clinical research through strategic planning, effective communication with stakeholders, and operational excellence.